Efficiency of expression of transfected genes depends on the cell cycle

被引:18
作者
Marenzi, S
Adams, RLP
Zardo, G
Lenti, L
Reale, A
Caiafa, P [1 ]
机构
[1] Univ Aquila, Dept Biomed Sci & Technol, I-67100 Laquila, Italy
[2] Univ Roma La Sapienza, Dept Biol Sci A Rossi Fanelli, Rome, Italy
[3] Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy
[4] Univ Roma La Sapienza, Dept Cellular Biotechnol & Ematol, Rome, Italy
[5] CNR, Ctr Mol Biol, Rome, Italy
[6] Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland
关键词
acetylation; cell cycle; expression of reporter gene; transfection;
D O I
10.1023/A:1007009022336
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipofection, a lipid-mediated DNA transfection procedure, was used to transfect synchronized L929 mouse fibroblast cells with a reporter plasmid containing the bacterial chloramphenicol acetyltransferase gene. The efficiency of gene expression was investigated on transfection of cells at different stages of the cell cycle. Our data show that expression of the reporter gene was minimal when transfection was performed in G0-phase and parallel experimental data disproved the possibility that the reduced expression observed was due to differential uptake at different times in the cell cycle. Investigation into the condensation state of the plasmid has shown that the low chloramphenicol acetyltransferase gene expression could be a direct consequence of the packaging of the plasmid into condensed chromatin when transfection occurs in G0-phase. The inactivation of the reporter gene is not reversed by growth of the cells in high serum or by treatment with Trichostatin A, a specific inhibitor of histone deacetylase, suggesting that the inactive chromatin formed in G0-phase cells lacks associated histone acetylase activity. In contrast, the high activity seen when cells in S-phase are transfected is enhanced even further by treatment with Trichostatin A.
引用
收藏
页码:261 / 267
页数:7
相关论文
共 36 条
[1]  
ADAMS RLP, 1993, CELL CULTURE BIOCH, P142
[2]  
Boulikas T, 1996, INT J ONCOL, V9, P1239
[3]  
Boulikas T, 1996, ONCOL REP, V3, P989
[4]  
BOULIKAS T, 1996, GEN THER MOL BIOL, V1, P1
[5]  
BRADBURY EM, 1992, BIOESSAYS, V14, P9
[6]  
CARUSO M, 1993, ONCOGENE, V8, P267
[7]   RETROVIRAL VECTOR PARTICLES DISPLAYING THE ANTIGEN-BINDING SITE OF AN ANTIBODY ENABLE CELL-TYPE-SPECIFIC GENE-TRANSFER [J].
CHU, THT ;
DORNBURG, R .
JOURNAL OF VIROLOGY, 1995, 69 (04) :2659-2663
[8]   Toward highly efficient cell-type-specific gene transfer with retroviral vectors displaying single-chain antibodies [J].
Chu, THT ;
Dornburg, R .
JOURNAL OF VIROLOGY, 1997, 71 (01) :720-725
[9]   Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector [J].
Dong, JY ;
Wang, DH ;
VanGinkel, FW ;
Pascual, DW ;
Frizzell, RA .
HUMAN GENE THERAPY, 1996, 7 (03) :319-331
[10]   Viral gene delivery to skeletal muscle: Insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type 1 viral vectors [J].
Feero, WG ;
Rosenblatt, JD ;
Huard, J ;
Watkins, SC ;
Epperly, M ;
Clemens, PR ;
Kochanek, S ;
Glorioso, JC ;
Partridge, TA ;
Hoffman, EP .
HUMAN GENE THERAPY, 1997, 8 (04) :371-380